Amyloidosis Clinical Trials
A listing of Amyloidosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 210 clinical trials
A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease
Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Clinical symptoms of the disease may begin with occasional forgetfulness such as misplacement of items, forgetting important dates or events, and may progress to noticeable memory loss, increased confusion …
- 0 views
- 12 Sep, 2023
- 1 location
RB-ADSC for Treatment of Mild to Moderate Alzheimer's Disease
The Primary objective of this phase 1 research study is to evaluate the safety of different(escalating) doses of the participant’s own stem cells as a part of our ongoing researchinto an effective “whole brain” treatment for Alzheimer disease, with secondaryobjectives to evaluate preliminary efficacy, in order to determine a recommended …
- 0 views
- 06 Sep, 2023
- 1 location
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
216 weeks of treatment (A45 Trial) and to determine whether treatment with BAN2401 is superior to placebo in reducing brain amyloid accumulation as measured by amyloid positron emission tomography
- 44 views
- 18 Jul, 2023
- 5 locations
Valacyclovir for Mild Cognitive Impairment (VALMCI)
Anti-viral treatment in Mild Cognitive Impairment (MCI) is a Phase II, placebo-controlled, 52-week trial using oral valacyclovir 4 g/day in 50 HSV seropositive, AD biomarker-positive, amnestic mild cognitive impairment (MCI) patients (eMCI and lMCI). The trial will directly address the long-standing viral etiology hypothesis of Alzheimer's disease (AD) which posits …
- 156 views
- 12 Apr, 2023
- 1 location
A PHASE III, MULTICENTER, RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF GANTENERUMAB IN PARTICIPANTS AT RISK FOR OR AT THE EARLIEST STAGES OF ALZHEIMER’S DISEASE
This study is designed to evaluate the efficacy and safety of Gantenerumab in participants at risk for or at the earliest stages of Alzheimer’s Disease (AD)
- 4 views
- 24 Jun, 2022
- 1 location
Participants Needed: Brain Imaging Research Study on Alzheimer’s Disease and Mild Cognitive Impairment
Participants diagnosed with Alzheimer’s Disease (AD) or Mild Cognitive Impairment (MCI) will receive an amyloid PET scan to help confirm AD diagnosis, as well as other noninvasive brain imaging
- 6 views
- 18 Jul, 2023
- 1 location
Impact of sleep apnea and its treatment on memory and tau accumulation in the brain
may be a modifiable risk factor for AD. This study will build on that by evaluating the effect of PAP treatment on markers of AD, such as amyloid beta (Aβ), Tau levels, and neurofilament light chain
- 12 views
- 25 Mar, 2022
- 1 location
1 Florida Alzheimer’s Disease Research Center (1FL ADRC)
This study aims to work with Researchers throughout the state of Florida to study the aging brain and learn more about how to detect and treat brain changes that affect memory during aging. Your participation will help increase the overall knowledge of Alzheimer’s disease and related dementias, and it will …
- 0 views
- 02 Feb, 2023
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease
A Randomized, Double-Blinded, Placebo-Controlled Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB037 in Subjects With Prodromal or Mild Alzheimer's Disease
- 87 views
- 25 Mar, 2021
- 1 location
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease
- 258 views
- 08 Dec, 2020
- 1 location